New England Research & Management, Inc. / LLY
New England Research & Management, Inc.’s Eli Lilly & Co Position
Does New England Research & Management, Inc. own Eli Lilly & Co (LLY)? Yes — 3.6K shares worth $4M (+1.66% of its 13F portfolio) as of Q2 2026, up from 3.2K shares the prior filed quarter.
Position Value
$4M
Q2 2026
Shares
3.6K
% of Portfolio
+1.66%
Quarters Held
27
currently held
Position History LLY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2026 | 3.6K | $4M | +1.66% |
| Q1 2026 | 3.2K | $3M | +1.23% |
| Q4 2025 | 2.4K | $3M | +1.12% |
| Q3 2025 | 2.4K | $2M | +0.86% |
| Q2 2025 | 2.8K | $2,183 | +1.04% |
| Q1 2025 | 2.7K | $2,239 | +1.14% |
| Q4 2024 | 2.4K | $1,854 | +0.94% |
| Q3 2024 | 2.6K | $2,309 | +1.08% |
| Q2 2024 | 2.0K | $1,771 | +0.85% |
| Q1 2024 | 2.2K | $1,697 | +0.83% |
| Q4 2023 | 2.7K | $1,594 | +0.84% |
| Q3 2023 | 1.7K | $908 | +0.52% |
| Q2 2023 | 1.8K | $842 | +0.49% |
| Q1 2023 | 2.8K | $960 | +0.56% |
| Q4 2022 | 1.5K | $547 | +0.31% |
| Q3 2022 | 1.5K | $483,000 | +0.30% |
| Q2 2022 | 1.3K | $417,000 | +0.24% |
| Q1 2022 | 1.4K | $411,000 | +0.21% |
| Q4 2021 | 1.3K | $362,000 | +0.18% |
| Q3 2021 | 1.3K | $303,000 | +0.16% |
| Q2 2021 | 3.0K | $682,000 | +0.35% |
| Q1 2021 | 1.4K | $260,000 | +0.14% |
| Q4 2020 | 5.7K | $956,000 | +0.59% |
| Q3 2020 | 11.9K | $2M | +1.27% |
| Q4 2019 | 12.6K | $2M | +1.11% |
| Q3 2019 | 12.8K | $1M | +1.04% |
| Q2 2019 | 9.2K | $1M | +0.69% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See New England Research & Management, Inc.’s full portfolio or all institutional holders of LLY.